Gilbert Tang, MD, surgical director of the structural heart program at the Mount Sinai Health System, discussed a key challenge care teams often encounter during tricuspid valve procedures. 

Abbott already has an FDA-approved self-expanding TAVR valve, the Navitor system, on the market. The company is now evaluating the safety and effectiveness of a new balloon-expandable device that could potentially be implanted using software guidance. 

See What’s New:

New research into post-concussion brain health suggests that the impact of head trauma may be more far-reaching than previously believed. 

The FDA’s fledgling Digital Health Advisory Committee (DHAC) only held its first meeting last week, but it has already committed its thinking to writing. 

The pressure changes associated with contrast injections are minimal, researchers noted, especially once you move away from the tip of the catheter. 

41 members of the upper chamber recently penned a letter to colleagues, contending that inaction could impact seniors’ access to care. 

Embolization is a safe, cost-effective alternative to a hysterectomy, but patients are not using the IR service in some geographies. 

The deal is with the Ohio State Wexner Medical Center, covering equipment purchases and consulting services. 

The Food and Drug Administration approval comes amid growing interest in remote-scan technology following the COVID pandemic.